Reading a patient's immune system will fundamentally transform healthcare by enabling earlier disease detection and treatment  

Check - Elements Webflow Library - BRIX Templates
The most effective way to minimize the impact of disease is to identify it early when treatment is the most effective, however, current diagnostic processes generally detect diseases at late stages when treatment is more problematic (see chart).
Check - Elements Webflow Library - BRIX Templates
Each person’s immune system identifies diseases early before symptoms; breakthroughs in AI now facilitates its decoding.
Check - Elements Webflow Library - BRIX Templates
To effectively harness this diagnostic power, another breakthrough is needed … a means of bringing this capability to attending clinicians in all healthcare settings.
Check - Elements Webflow Library - BRIX Templates
Immune IQ has created such a system … Immune Reveal … to enable healthcare organizations to identify and treat diseases earlier thereby significantly reducing disabilities and death.

AI decoding of the immune system will revolutionize global healthcare

“By breaking the code of the immune system, we believe we will be able to determine your state of health and your response to therapies in essentially every human disease.”

J. Epstein, MD, Chief Scientific Officer, Penn Medicine​

Immune Reveal – 100 patents

Briefcase Icon - Elements Webflow Library - BRIX Templates

Comprehensive Disease Scanning

Immune Reveal simultaneous scans for many diseases making regular screening viable in terms of time and cost

Desktop - Elements Webflow Library - BRIX Templates

High accuracy

The immune system has higher accuracy than many of today’s confirmatory tests and has inherently a very low false-positive rate

Users - Elements Webflow Library - BRIX Templates

Early detection

The immune system excels at early disease detection before symptoms when treatment is most effective

Gear - Elements Webflow Library - BRIX Templates

Widely accessible to make disease screening easy

Easy-to-use point-of-care (POC) analyzer can be used by healthcare professionals in all care settings

Reports - Elements Webflow Library - BRIX Templates

Low cost facilitates broad adoption and frequent use

3M tape technology enables a multi-disease test cartridge  to be available for less than $20  

Password - Elements Webflow Library - BRIX Templates

Small size fits everywhere

Honeywell micro-fluidic technology enables miniaturization​ resulting in an countertop instrument less than a foot wide

Clinical Results

Check - Elements Webflow Library - BRIX Templates
In a month-long, hands-off clinical study at Massachusetts General Hospital, the Immune Reveal™️ demonstrated the ability to reliably generate its advanced dataset​.
Check - Elements Webflow Library - BRIX Templates
In a preliminary clinical study, the Immune Reveal demonstrated superior results for COVID identification compared to the gold standard method (PCR).
Check - Elements Webflow Library - BRIX Templates
Immune Reveal’s dataset is more effective at initial recognition of a high-risk of sepsis than the current process (94% vs. 30%).
Check - Elements Webflow Library - BRIX Templates
A retrospective clinical study for lung cancer demonstrated that Immune Reveal’s second generation dataset has comparable performance to a CT scan and cell-free DNA.
Check - Elements Webflow Library - BRIX Templates
Next clinical studies include sepsis identification (Johns Hopkins), Long-COVID identification (NYU) and food allergy (Rocky Mountain Allergy).

Immune Reveal Benefits

The Immune Reveal's comprehensive screening will enable a broader implementation of proactive care

Reactive Healthcare

The predominant care approach today is reactive care (treatment when patients are visibly ill).

Proactive Healthcare

The proactive care approach focuses on intercepting diseases before symptoms when treatment is most effective and less costly.


The Immune Reveal enables proactive care and accelerates the current reactive care process

Health Screen

Check - Elements Webflow Library - BRIX Templates
Enables early detection of progressing diseases (cancer, IBD, etc.) ​before symptoms when treatment is most effective
Check - Elements Webflow Library - BRIX Templates
As a standard practice, patients could be tested every 6-12 months at a convenient site (clinic, retail clinic, pharmacy, nursing homes, even a dental office)

Acute Disease Screen

Check - Elements Webflow Library - BRIX Templates
Identifies most probable disease(s) responsible for symptoms and co-morbidities to accelerate treatment of critically ill patients (sepsis, appendicitis, etc.)​
Check - Elements Webflow Library - BRIX Templates
All acutely ill patients with an unknown illness could receive a 5-minute test to assist in identifying the underlying condition

Immune Reveal will help increase the ability to identify diseases in underserved areas of the world

The ability to identify diseases is not widely available in much of the world

The Lancet Commission on Diagnostics, estimates that nearly half of the global population lack access to basic diagnostics for many common diseases

Low-cost, ease of use and direct disease identification will expand access to disease identification globally

One of Immune IQ’s goals is to provide a 5-minute disease scanning panel for the 50 most important  diseases found in developing countries – for under $8

App and AI-Decoding Disease Menu Expansion

Novel app-based disease menu expansion drives new tests ​

Check - Elements Webflow Library - BRIX Templates
Efficient Test Expansion
It's crucial that a comprehensive screening platform be able to efficiently add tens or hundreds of new disease identification tests.​
Check - Elements Webflow Library - BRIX Templates
Point-of-Care Challenges
Test menu expansion has been the largest challenge for point-of-care (POC) diagnostic platforms.
Check - Elements Webflow Library - BRIX Templates
Test Cartridge Innovation
The combination of Immune IQ’s unique test cartridge system and a revolutionary AI based data evaluation process, enables both in-house and outside partner app development to progress rapid, cost effective menu expansion.

Immune IQ’s database enables best-in-class AI decoding of the immune system

Intelligence of AI is driven by data

The intelligence of an AI system, and its decoding ability, is a function of the amount of data available in its database for learning.

Immune IQ's data advantage will power its advanced AI immune decoding

The wide distribution potential of the Immune Reveal will generate ~100X greater patient data than dedicated lab systems, and that combined with its rich dataset, will facilitate the world’s largest homogeneous immune database.

Immune IQ's database enables rapid menu growth

Automated AI will interrogate the evolving dataset and enable automated expansion of the disease library.

Database facilitates drug development

Drug development partners will utilize IIQ’s database to accelerate drug development and create new companion diagnostics.

​World-class Team Enables Extraordinary Results

Gear - Elements Webflow Library - BRIX Templates

Point-of-Care & AI Innovators

The founders have started two previous point-of-care diagnostic companies (IPO (NASDAQ) for one and the other was acquired leading to $1B/yr product line). They also started a financial services AI company enabling complex financial services for JPMorgan, Citigroup & Merrill Lynch.

Users - Elements Webflow Library - BRIX Templates

Technology Partners

Technology partners include Honeywell and the Battelle Institute, the world’s largest independent R&D organization.

Building Icon - Elements Webflow Library - BRIX Templates

Healthcare Champions

Immune IQ has relationships with both Johns Hopkins and Massachusetts General Hospital.

strategic partnership

Battelle, the World’s Largest
Independent R&D Organization

Support - Elements Webflow Library - BRIX Templates

App Based Menu

Battelle's support of ImmuneIQ extends to facilitating app-based menu expansion, ensuring the platform remains dynamic and adaptable to evolving healthcare needs.

Support - Elements Webflow Library - BRIX Templates

Network Intelligence

Battelle's network intelligence capabilities can optimize data transmission and processing, enhancing the efficiency of disease identification algorithms.

Support - Elements Webflow Library - BRIX Templates

Integrated Circuits

Through collaboration on integrated circuits, ImmuneIQ benefits from cutting-edge hardware solutions that maximize the performance of point-of-care analyzers.

Support - Elements Webflow Library - BRIX Templates

Instrument Family

By incorporating Battelle's expertise in developing instrument families, ImmuneIQ can streamline production and ensure consistency across their diagnostic systems.

Support - Elements Webflow Library - BRIX Templates

Machine Learning

Battelle's involvement in machine learning initiatives empowers ImmuneIQ in refining algorithms and improving the accuracy and scope of disease detection.

Support - Elements Webflow Library - BRIX Templates

Clinical Units

Lastly, by leveraging Battelle's clinical units, ImmuneIQ gains access to diverse testing environments for validating technology in real-world healthcare settings.

Clear Path to FDA Submission

Instrument Status

Check - Elements Webflow Library - BRIX Templates
Validated in hands-off clinical studies​
Check - Elements Webflow Library - BRIX Templates
Manufactured in the United Stated by Veranex, an industry leader​

Disposable Test Cards​

Check - Elements Webflow Library - BRIX Templates
Proprietary manufacturing process and equipment of the tape-based test cartridges enables low-cost per test and commercialization
Check - Elements Webflow Library - BRIX Templates
$250M of product can be produced annually in 10,000 ft2 production space​

Regulatory

Check - Elements Webflow Library - BRIX Templates
Sepsis (Johns Hopkins), long-COVID (NYU) and complete-blood-count (CBC) clinical trials for the FDA approval process
Check - Elements Webflow Library - BRIX Templates
Positioned to receive FDA Breakthrough Device Designation enabling accelerated pre-market approval​
Check - Elements Webflow Library - BRIX Templates
The Immune RevealTM system has not yet been reviewed by the FDA or any other regulatory entities

Meet Our Team Members

Our team comprises seasoned industry veterans driving innovation, manufacturing, and technological advancements to revolutionize healthcare diagnostics.

CEO, Founder

Previously founded two other point-of-care blood testing companies, one of which completed a successful IPO on NASDAQ. The second was acquired by a large diagnostic company and the base technology is responsible for over $1B/yr in sales. Founded a company which led the early adoption of AI for wealth management, restricted stock, and retirement planning (JPMorgan, Citigroup and Merrill Lynch).

MD  - Advisory board

Dr. Fackler, in Critical Care Medicine at Johns Hopkins Hospital, spearheads advancements in the rapidly growing field of artificial intelligence in medicine, pioneering transformative approaches and applications.




COO, Founder

Recognized leader in machine-learning-based manufacturing of complex POC disposables. She was previously involved in two successful POC blood-testing startups, one purchased by J&J and the other, where she served as Vice-President of Manufacturing, went public on NASDAQ.​

MD - Advisory board

Dr. Adalja, a Senior Scholar at Johns Hopkins Center for Health Security, is a pivotal expert in infectious diseases, particularly renowned for his contributions to understanding and addressing COVID-19, guiding responses and empowering stakeholders amid unprecedented challenges.

Michael is a prominent  leader in the development of complex POC instruments. He has over 25 years of IVD and medical device product development, operations, and manufacturing experience. He has been led teams as COO and CTO in the development of hundreds of medical, IVD, and consumer-centric products in a variety of roles.​

MD - Advisory board

Dr. Parikh, extensively published and a sought-after speaker on Long-COVID, co-founds the Parikh Institute of Research, pioneering investigations in allergies, asthma, and immunology trials, boasting affiliations with Albert Einstein College of Medicine, Cleveland Clinic, and NYU Grossman School of Medicine.

International finance leader with proven ability to build and position companies for long-term growth/profitability. Public company, private equity, family company, start-up and acquisition/divestiture experience across multiple industries, geographies, and scale of businesses. Expertise in development and implementation of strategic business.

MD - Advisory board

Dr. Jones, founder and director of Rocky Mountain Allergy at Tanner Clinic in Layton, Utah, and Immunity Group Australia in Sydney, exemplifies leadership and expertise in the field of allergy and immunology on a global scale.